secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2025-02-12T23:59:59+00:00
Accession:  0001493152-25-006126
Event type: debt
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma raises $108K in two convertible note financings in Feb 2025
-----------------------------------------------------------------------------

- $65,000 convertible note (purchase price $56,000) issued Feb 6; 15% flat interest, maturity Nov 30, 2025.
- $43,000 convertible note (purchase price $40,000) issued Feb 10; 8% annual interest, maturity Oct 7, 2025.
- First note convertible at 35% discount to lowest 10-day trading price; second note at $9/share (or $6 if stock <$8 for 5 days).
- Proceeds used for general working capital; notes sold in unregistered offerings under Rule 506(b) and Section 4(a)(2).
- Both notes contain events of default including failure to pay, breach of covenants, and conversion share issuance delays.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315225006126/0001493152-25-006126-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315225006126/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-006126

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer